drugset / Trial / NCT01891461
Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR
Phase 4
Completed
132 enrolled
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Baxter Healthcare Corporation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare Floseal to our standard of care (SOC) to decrease intraoperative and immediate post-operative bleeding.
Timeline
- Start
- 2012-01
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Floseal | Other / unclassified | 5 ml | Topical |
Indications
No indication recorded.